vs

Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Postal Realty Trust, Inc. (PSTL). Click either name above to swap in a different company.

ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $26.0M, roughly 1.5× Postal Realty Trust, Inc.). Postal Realty Trust, Inc. runs the higher net margin — 17.9% vs -161.8%, a 179.7% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 21.7%). Postal Realty Trust, Inc. produced more free cash flow last quarter ($37.6M vs $-71.3M).

ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.

Postal Realty Trust, Inc. is a specialized real estate investment trust that acquires, owns, and manages properties primarily leased to the United States Postal Service. Its portfolio includes last-mile postal facilities, sorting centers, and retail post office locations across the U.S., supporting critical mail and package delivery infrastructure.

IBRX vs PSTL — Head-to-Head

Bigger by revenue
IBRX
IBRX
1.5× larger
IBRX
$38.3M
$26.0M
PSTL
Growing faster (revenue YoY)
IBRX
IBRX
+385.3% gap
IBRX
407.0%
21.7%
PSTL
Higher net margin
PSTL
PSTL
179.7% more per $
PSTL
17.9%
-161.8%
IBRX
More free cash flow
PSTL
PSTL
$108.8M more FCF
PSTL
$37.6M
$-71.3M
IBRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IBRX
IBRX
PSTL
PSTL
Revenue
$38.3M
$26.0M
Net Profit
$-61.9M
$4.6M
Gross Margin
99.0%
Operating Margin
-169.0%
39.2%
Net Margin
-161.8%
17.9%
Revenue YoY
407.0%
21.7%
Net Profit YoY
-4.7%
3.1%
EPS (diluted)
$-0.06
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBRX
IBRX
PSTL
PSTL
Q4 25
$38.3M
$26.0M
Q3 25
$32.1M
$24.3M
Q2 25
$26.4M
$23.4M
Q1 25
$16.5M
$22.1M
Q4 24
$7.6M
$21.4M
Q3 24
$6.1M
$19.7M
Q2 24
$18.1M
Q1 24
$17.3M
Net Profit
IBRX
IBRX
PSTL
PSTL
Q4 25
$-61.9M
$4.6M
Q3 25
$-67.3M
$3.8M
Q2 25
$-92.6M
$3.6M
Q1 25
$-129.6M
$2.1M
Q4 24
$-59.2M
$4.5M
Q3 24
$-85.7M
$1.1M
Q2 24
$817.0K
Q1 24
$206.0K
Gross Margin
IBRX
IBRX
PSTL
PSTL
Q4 25
99.0%
Q3 25
99.4%
Q2 25
99.5%
Q1 25
99.6%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
IBRX
IBRX
PSTL
PSTL
Q4 25
-169.0%
39.2%
Q3 25
-173.5%
37.6%
Q2 25
-269.8%
37.3%
Q1 25
-390.1%
28.4%
Q4 24
-919.0%
43.2%
Q3 24
-1314.3%
24.3%
Q2 24
22.8%
Q1 24
17.6%
Net Margin
IBRX
IBRX
PSTL
PSTL
Q4 25
-161.8%
17.9%
Q3 25
-209.8%
15.7%
Q2 25
-350.3%
15.5%
Q1 25
-784.9%
9.4%
Q4 24
-783.4%
21.1%
Q3 24
-1404.0%
5.4%
Q2 24
4.5%
Q1 24
1.2%
EPS (diluted)
IBRX
IBRX
PSTL
PSTL
Q4 25
$-0.06
$0.16
Q3 25
$-0.07
$0.13
Q2 25
$-0.10
$0.12
Q1 25
$-0.15
$0.06
Q4 24
$-0.08
$0.17
Q3 24
$-0.14
$0.03
Q2 24
$0.02
Q1 24
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBRX
IBRX
PSTL
PSTL
Cash + ST InvestmentsLiquidity on hand
$242.8M
$1.5M
Total DebtLower is stronger
$361.1M
Stockholders' EquityBook value
$-500.5M
$285.2M
Total Assets
$501.9M
$759.1M
Debt / EquityLower = less leverage
1.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBRX
IBRX
PSTL
PSTL
Q4 25
$242.8M
$1.5M
Q3 25
$257.8M
$1.9M
Q2 25
$153.7M
$1.1M
Q1 25
$61.6M
$639.0K
Q4 24
$149.8M
$1.8M
Q3 24
$130.4M
$970.0K
Q2 24
$1.7M
Q1 24
$1.9M
Total Debt
IBRX
IBRX
PSTL
PSTL
Q4 25
$361.1M
Q3 25
$347.0M
Q2 25
$328.8M
Q1 25
$306.7M
Q4 24
$296.7M
Q3 24
$277.0M
Q2 24
$273.7M
Q1 24
$247.6M
Stockholders' Equity
IBRX
IBRX
PSTL
PSTL
Q4 25
$-500.5M
$285.2M
Q3 25
$-524.3M
$273.9M
Q2 25
$-570.7M
$250.8M
Q1 25
$-591.4M
$245.5M
Q4 24
$-489.1M
$251.3M
Q3 24
$-745.1M
$245.6M
Q2 24
$245.5M
Q1 24
$248.1M
Total Assets
IBRX
IBRX
PSTL
PSTL
Q4 25
$501.9M
$759.1M
Q3 25
$519.0M
$735.2M
Q2 25
$402.1M
$689.8M
Q1 25
$303.8M
$654.0M
Q4 24
$382.9M
$646.8M
Q3 24
$364.6M
$615.1M
Q2 24
$608.2M
Q1 24
$584.1M
Debt / Equity
IBRX
IBRX
PSTL
PSTL
Q4 25
1.27×
Q3 25
1.27×
Q2 25
1.31×
Q1 25
1.25×
Q4 24
1.18×
Q3 24
1.13×
Q2 24
1.11×
Q1 24
1.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBRX
IBRX
PSTL
PSTL
Operating Cash FlowLast quarter
$-70.4M
$44.5M
Free Cash FlowOCF − Capex
$-71.3M
$37.6M
FCF MarginFCF / Revenue
-186.2%
144.5%
Capex IntensityCapex / Revenue
2.4%
26.7%
Cash ConversionOCF / Net Profit
9.59×
TTM Free Cash FlowTrailing 4 quarters
$-308.8M
$65.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBRX
IBRX
PSTL
PSTL
Q4 25
$-70.4M
$44.5M
Q3 25
$-68.9M
$10.9M
Q2 25
$-79.7M
$11.4M
Q1 25
$-85.9M
$10.8M
Q4 24
$-85.1M
$33.5M
Q3 24
$-98.8M
$8.0M
Q2 24
$9.9M
Q1 24
$6.4M
Free Cash Flow
IBRX
IBRX
PSTL
PSTL
Q4 25
$-71.3M
$37.6M
Q3 25
$-69.6M
$8.8M
Q2 25
$-80.8M
$9.1M
Q1 25
$-87.0M
$10.2M
Q4 24
$-87.3M
$30.7M
Q3 24
$-101.6M
$7.4M
Q2 24
$8.9M
Q1 24
$5.8M
FCF Margin
IBRX
IBRX
PSTL
PSTL
Q4 25
-186.2%
144.5%
Q3 25
-217.2%
36.1%
Q2 25
-305.9%
38.8%
Q1 25
-526.9%
45.9%
Q4 24
-1155.4%
143.8%
Q3 24
-1663.2%
37.6%
Q2 24
49.4%
Q1 24
33.6%
Capex Intensity
IBRX
IBRX
PSTL
PSTL
Q4 25
2.4%
26.7%
Q3 25
2.3%
8.9%
Q2 25
4.1%
10.1%
Q1 25
6.8%
3.0%
Q4 24
28.0%
13.0%
Q3 24
45.7%
3.2%
Q2 24
5.4%
Q1 24
3.5%
Cash Conversion
IBRX
IBRX
PSTL
PSTL
Q4 25
9.59×
Q3 25
2.87×
Q2 25
3.16×
Q1 25
5.20×
Q4 24
7.44×
Q3 24
7.48×
Q2 24
12.10×
Q1 24
31.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons